BioInsights - Thinking translational: Things to consider in CAR T cell research workflows
Jun
22
2022
On demand

Thinking translational: Things to consider in CAR T cell research workflows

Sponsor
Thinking translational: Things to consider in CAR T cell research workflows

Developing safe and effective CAR T cell therapies is a challenging task. That’s why thinking translational early in research experiments is important. Suitable tools will later enable a smooth transition from small-scale to large-scale workflows.

Join us as we discuss how to set up your small-scale research workflow to ease up the transition to large-scale manufacturing in preclinical development.

  • Learn about key considerations for every step of your workflow including cell separation, culture, and analysis
  • Get to know solutions specially developed for a smooth transition to cell manufacturing
  • What´s new? – Latest developments for CAR T cell research and manufacturing

Saskia Rösch, PhD

Global Product Manager, Miltenyi Biotec

Saskia Rösch, PhD, received her doctoral degree in Biology from the University of Heidelberg/DKFZ, Germany, in 2017. She continued her studies in Cancer Immunotherapy as a postdoctoral fellow at the University Hospital in Heidelberg, Germany, before joining Miltenyi Biotec as a Global Product Manager for T Cell Immunology and Gene-engineered T cells.

SPEAKERS

Saskia Rösch, PhD
Saskia Rösch, PhD
Global Product Manager at Miltenyi Biotec

You might also like

Pain points to potential: Positioning process and analytical development for next-gen cell therapies

Pain points to potential: Positioning process and analytical development for next-gen cell therapies

Sarah Campion, Alex Sargent
9 March 2023
in 41
Days
Register
Driving the expansion of mRNA into the therapeutic sphere

Driving the expansion of mRNA into the therapeutic sphere

D Becerra, A Kuhn, M Kurtoglu
23 February 2023
in 27
Days
Register
Development of lentiviral vector packaging and producer cell lines

Development of lentiviral vector packaging and producer cell lines

Matthew Tridgett, PhD
16 February 2023
in 20
Days
Register
Implementing a closed cell therapy manufacturing process through strategic collaboration

Implementing a closed cell therapy manufacturing process through strategic collaboration

X Mollerat du Jeu, Ø Åmellem, B Shy
14 February 2023
in 18
Days
Register
GMP-compliant manufacturing in a closed-system automated bioreactor with a novel cell culture medium

GMP-compliant manufacturing in a closed-system automated bioreactor with a novel cell culture medium

Gonçalo Regalo, Francesco Vitrani
13 December 2022
Watch